Increased anti-phospholipid antibodies in autism spectrum disorders

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Careaga, Milo ^a   Hansen, Robin L ^a,b   Hertz Piccotto, Irva ^a,b   Van De Water, Judy ^b,c   Ashwood, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY; PHOSPHOSERINE; CARDIOLIPIN; PHOSPHOLIPID;

ANTIBODY BLOOD LEVEL; ARTICLE; AUTISM; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; BLOOD; CHEMISTRY; COGNITIVE DEFECT; IMMUNOLOGY;

ANTIBODIES, ANTIPHOSPHOLIPID; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; CHILD; CHILD BEHAVIOR DISORDERS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; MALE; PHOSPHOLIPIDS; PHOSPHOSERINE;

EID: 84885670517     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/935608     Document Type: Article

References (47)

1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2008. Morbidity and Mortality Weekly Report 2012 61 3 1 19 2-s2.0-84859394070
2. Careaga M., van de Water J., Ashwood P., Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics 2010 7 3 283 292 2-s2.0-77954938884 10.1016/j.nurt.2010.05.003
3. Onore C., Careaga M., Ashwood P., The role of immune dysfunction in the pathophysiology of autism. Brain, Behavior, and Immunity 2012 26 3 383 392 2-s2.0-84857190395 10.1016/j.bbi.2011.08.007
4. Enstrom A. M., van de Water J. A., Ashwood P., Autoimmunity in autism. Current Opinion in Investigational Drugs 2009 10 5 463 473 2-s2.0-67649414374
5. Mostafa G. A., El-Sayed Z. A., El-Aziz M. M., El-Sayed M. F., Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. Journal of Child Neurology 2008 23 12 1413 1418 2-s2.0-57749174019 10.1177/0883073808319321
6. Wills S., Rossi C. C., Bennett J., Martinez-Cerdo V., Ashwood P., Amaral D. G., van de Water J., Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Molecular Autism 2011 2 1, article 5 2-s2.0-84855922674 10.1186/2040-2392-2-5
7. Goines P., Haapanen L., Boyce R., Duncanson P., Braunschweig D., Delwiche L., Hansen R., Hertz-Picciotto I., Ashwood P., van de Water J., Autoantibodies to cerebellum in children with autism associate with behavior. Brain, Behavior, and Immunity 2011 25 3 514 523 2-s2.0-79551687313 10.1016/j.bbi.2010.11.017
8. Kirkman N. J., Libbey J. E., Sweeten T. L., Coon H. H., Miller J. N., Stevenson E. K., Lainhart J. E., McMahon W. M., Fujinami R. S., How relevant are GFAP autoantibodies in autism and Tourette syndrome? Journal of Autism and Developmental Disorders 2008 38 2 333 341 2-s2.0-38549179973 10.1007/s10803-007-0398-9 (Pubitemid 351161424)
9. Libbey J. E., Coon H. H., Kirkman N. J., Sweeten T. L., Miller J. N., Stevenson E. K., Lainhart J. E., McMahon W. M., Fujinami R. S., Are there enhanced MBP autoantibodies in autism? Journal of Autism and Developmental Disorders 2008 38 2 324 332 2-s2.0-38549085855 10.1007/s10803-007-0400-6 (Pubitemid 351161426)
10. Long A. A., Ginsberg J. S., Brill-Edwards P., Johnston M., Turner C., Denburg Bensen J. A. W. G., Cividino A., Andrew M., Hirsh J., The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thrombosis and Haemostasis 1991 66 5 520 524 2-s2.0-0025994752
11. Zambon M., Cappelli D., Berlot G., Berlot G., Antiphospholipid antibody syndrome. Hemocoagulative Problems in the Critically Ill Patient 2012 Milan, Italy Springer 209 216
12. Sokol D. K., O'Brien R. S., Wagenknecht D. R., Rao T., McIntyre J. A., Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis. Journal of Neuroimmunology 2007 190 1-2 151 156 2-s2.0-35448930682 10.1016/j.jneuroim.2007.08.002 (Pubitemid 47625611)
13. Zandman-Goddard G., Chapman J., Shoenfeld Y., Autoantibodies Involved in neuropsychiatric SLE and antiphospholipid syndrome. Seminars in Arthritis and Rheumatism 2007 36 5 297 315 2-s2.0-34047106679 10.1016/j.semarthrit.2006.11.003 (Pubitemid 46517634)
14. Ziporen L., Shoenfeld Y., Levy Y., Korczyn A. D., Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. The Journal of Clinical Investigation 1997 100 3 613 619 2-s2.0-0030818836 (Pubitemid 27340509)
15. Shoenfeld Y., Ziporen L., Lessons from experimental APS models. Lupus 1998 7 2 S158 S161 2-s2.0-0031790330 (Pubitemid 28484603)
16. Cervera R., Piette J. C., Font J., Khamashta M. A., Shoenfeld Y., Camps M. T., Jacobsen S., Lakos G., Tincani A., Kontopoulou-Griva I., Galeazzi M., Meroni P. L., Derksen R. H. W. M., de Groot P. G., Gromnica-Ihle E., Baleva M., Mosca M., Bombardieri S., Houssiau F., Gris J.-C., Quéré I., Hachulla E., Vasconcelos C., Roch B., Fernández-Nebro A., Boffa M.-C., Hughes G. R. V., Ingelmo M., Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis & Rheumatism 2002 46 4 1019 1027 2-s2.0-0036228886 10.1002/art.10187 (Pubitemid 34303815)
17. Berkun Y., Kenet G., Pediatric antiphospholipid syndrome. Israel Medical Association Journal 2008 10 1 45 47 2-s2.0-41149127736 (Pubitemid 351649464)
18. Hertz-Picciotto I., Croen L. A., Hansen R., Jones C. R., van de Water J., Pessah I. N., The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environmental Health Perspectives 2006 114 7 1119 1125 2-s2.0-33745787015 10.1289/ehp.8483 (Pubitemid 44018911)
19. Ashwood P., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R. L., Croen L. A., Ozonoff S., Pessah I. N., van de Water J., Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. Journal of Neuroimmunology 2008 204 1-2 149 153 2-s2.0-54349091759 10.1016/j.jneuroim.2008.07.006
20. Enstrom A., Krakowiak P., Onore C., Pessah I. N., Hertz-Picciotto I., Hansen R. L., van de Water J. A., Ashwood P., Increased IgG4 levels in children with autism disorder. Brain, Behavior, and Immunity 2009 23 3 389 395 2-s2.0-61549093383 10.1016/j.bbi.2008.12.005
21. Lord C., Pickles A., McLennan J., Rutter M., Bregman J., Folstein S., Fombonne E., Leboyer M., Minshew N., Diagnosing autism: analyses of data from the autism diagnostic interview. Journal of Autism and Developmental Disorders 1997 27 5 501 517 2-s2.0-0030773652 (Pubitemid 27513149)
22. Joseph R. M., Tager-Flusberg H., Lord C., Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. Journal of Child Psychology and Psychiatry and Allied Disciplines 2002 43 6 807 821 2-s2.0-0042855814 10.1111/1469-7610.00092 (Pubitemid 36939261)
23. American Psychiatric Association, Task Force on D-I. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 2000 Washington, DC, USA American Psychiatric Association
24. Steinhausen H. C., Erdin A., Abnormal psychosocial situations and ICD-10 diagnoses in children and adolescents attending a psychiatric service. Journal of Child Psychology and Psychiatry and Allied Disciplines 1992 33 4 731 740 2-s2.0-0026563033 10.1111/j.1469-7610.1992.tb00908.x
25. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D., van de Water J., Autoantibodies in autism spectrum disorders (ASD). Annals of the New York Academy of Sciences 2007 1107 79 91 2-s2.0-34648820674 10.1196/annals.1381.009 (Pubitemid 47528784)
26. Avcin T., Ambrozic A., Bozic B., Accetto M., Kveder T., Rozman B., Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Clinical and Experimental Rheumatology 2002 20 1 101 108 (Pubitemid 34213744)
27. Erkan D., Kozora E., Lockshin M. D., Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome. Pathophysiology 2011 18 1 93 102 2-s2.0-78650525662 10.1016/j.pathophys.2010.04.010
28. Miesbach W., Gilzinger A., Gökpinar B., Claus D., Scharrer I., Prevalence of antiphospholipid antibodies in patients with neurological symptoms. Clinical Neurology and Neurosurgery 2006 108 2 135 142 2-s2.0-30444457880 10.1016/j.clineuro.2005.03.005 (Pubitemid 43075531)
29. Shoenfeld Y., Nahum A., Korczyn A. D., Dano M., Rabinowitz R., Beilin O., Pick C. G., Leider-Trejos L., Kalashnikova L., Blank M., Chapman J., Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 2003 12 6 436 442 2-s2.0-0038607739 10.1191/0961203303lu409oa (Pubitemid 36830116)
30. Menachem A., Chapman J., Katzav A., Hyperactivity induced by antiphospholipid syndrome serum. Annals of the New York Academy of Sciences 2009 1173 422 426 2-s2.0-69949122492 10.1111/j.1749-6632.2009.04876.x
31. Sanna G., Bertolaccini M. L., Cuadrado M. J., Khamashta M. A., Hughes G. R., Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 2003 42 2 200 213 2-s2.0-0037297397 10.1093/rheumatology/ keg080 (Pubitemid 36305604)
32. Andreoli L., Tincani A., Beyond the "syndrome": antiphospholipid antibodies as risk factors. Arthritis & Rheumatism 2012 64 2 342 345 2-s2.0-84856388449 10.1002/art.33341
33. Khamashta M. A., Gil A., Anciones B., Lavilla P., Valencia M. E., Pintado V., Vazquez J. J., Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies. Annals of the Rheumatic Diseases 1988 47 8 681 683 2-s2.0-0023784099
34. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D. G., van de Water J., Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain, Behavior, and Immunity 2009 23 1 64 74 2-s2.0-56949085021 10.1016/j.bbi.2008.07.007
35. Lavazza T., Dipinto A., Borghi M. O., Usuelli V., Beigamaschi A., Zimarino V., Antiphospholipid antibodies and central nervous system involvement: direct autoantibody binding to neuronal cells. Clinical and Experimental Rheumatology 2007 25 147
36. Chapman J., Cohen-Armon M., Shoenfeld Y., Korczyn A. D., Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999 8 2 127 133 2-s2.0-0032908439 (Pubitemid 29103599)
37. Sun K. H., Liu W. T., Tsai C. Y., Liao T. S., Lin W. M., Yu C. L., Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Annals of the Rheumatic Diseases 1992 51 6 707 712 2-s2.0-0026763468
38. Khalili A., Cooper R. C., A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE). Clinical and Experimental Immunology 1991 85 3 365 372 2-s2.0-0025770187
39. Rossi C. C., van de Water J., Rogers S. J., Amaral D. G., Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders. Brain, Behavior, and Immunity 2011 25 6 1123 1135 2-s2.0-79960228390 10.1016/j.bbi.2011.02.011
40. Todd R. D., Ciaranello R. D., Demonstration of inter-and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proceedings of the National Academy of Sciences of the United States of America 1985 82 2 612 616 2-s2.0-0021999839 (Pubitemid 15128319)
41. Singh V. K., Warren R. P., Odell J. D., Warren W. L., Cole P., Antibodies to myelin basic protein in children with autistic behavior. Brain, Behavior, and Immunity 1993 7 1 97 103 2-s2.0-0027220071 10.1006/brbi.1993.1010 (Pubitemid 23227066)
42. Singh V. K., Rivas W. H., Detection of antinuclear and antilaminin antibodies in autistic children who received thimerosal-containing vaccines. Journal of Biomedical Science 2004 11 5 607 610 2-s2.0-4444225180 10.1159/000079672 (Pubitemid 39179124)
43. Singh V. K., Warren R., Averett R., Ghaziuddin M., Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatric Neurology 1997 17 1 88 90 2-s2.0-0030886961 10.1016/S0887-8994(97)00045-3 (Pubitemid 27387929)
44. Blank M., Asherson R. A., Cervera R., Shoenfeld Y., Antiphospholipid syndrome infectious origin. Journal of Clinical Immunology 2004 24 1 12 23 2-s2.0-1642390876 10.1023/B:JOCI.0000018058.28764.ce (Pubitemid 38375790)
45. Shoenfeld Y., Blank M., Cervera R., Font J., Raschi E., Meroni P. L., Infectious origin of the antiphospholipid syndrome. Annals of the Rheumatic Diseases 2006 65 1 2 6 2-s2.0-29144479891 10.1136/ard.2005.045443 (Pubitemid 41815631)
46. Atladottir H. O., Henriksen T. B., Schendel D. E., Parner E. T., Using maternally reported data to investigate the association between early childhood infection and autism spectrum disorder: the importance of data source. Paediatric and Perinatal Epidemiology 2012 26 373 385
47. Rosen N. J., Yoshida C. K., Croen L. A., Infection in the first 2 years of life and autism spectrum disorders. Pediatrics 2007 119 1 e61 e69 2-s2.0-33846913527 10.1542/peds.2006-1788 (Pubitemid 46397806)